As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world.

Dr. Salimi Elizei investigated the anti-inflammatory role of the tryptophan degrading enzyme (IDO) and downstream metabolites on T Helper 17 cells, which have been connected to inflammatory and autoimmune disorders. She subsequently showed that IDO cell therapy improved the disease condition in psoriasis-like dermatitis.

A randomly-selected Doctoral citation each day: today from the Doctor of Philosophy in Experimental Medicine (PhD) - graduated in 2017